Evidence map›Paper›PMID 40672312›Full record

ArticlebioRxiv : the preprint server for biology2025

Closing the loop: Teaching single-cell foundation models to learn from perturbations.

Yash Pershad, Tarak N Nandi, Joseph C Van Amburg, Alyssa C Parker, Luiza Ostrowski, Hannah K Giannini, David Ong, J Brett Heimlich, Esther A Obeng, Katrin Ericson and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Machine Learning for CRISPR-Based Diagnostics.International journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yash PershadDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-2282-1403
Tarak N NandiData Science and Learning, Argonne National Laboratory, Lemont, IL, USA.ORCID 0000-0002-7050-6619
Joseph C Van AmburgDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-1410-6995
Alyssa C ParkerDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-6632-7458
Luiza OstrowskiKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Hannah K GianniniDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-7672-4716
David OngDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
J Brett HeimlichDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0003-2812-5326
Esther A ObengDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0002-8691-7439
Katrin EricsonRUNX1 Research Program, Santa Barbara, California, USA.
Anupriya AgarwalKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Ravi K MadduriData Science and Learning, Argonne National Laboratory, Lemont, IL, USA.ORCID 0000-0003-2130-2887
Alexander G BickDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-5824-9595

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Clonal Hematopoiesis Aging Resiliency MechanismsR01AG088657 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Alexander Bick, Siddhartha Jaiswal · 2024 to 2026
$6.6M
Training Program on Genetic Variation and Human PhenotypesT32GM080178 · NIGMS · VANDERBILT UNIVERSITY · PI COX, NANCY J, SAMUELS, DAVID C · 2007 to 2021
$3.1M
Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequencesR01AG083736 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul L. Auer, Alexander Bick · 2023 to 2026
$2.8M
Inflammation-Driven Clonal Evolution in RUNX1 Carriers: Mechanisms and Therapeutic VulnerabilitiesR01HL155426 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Anupriya Agarwal · 2021 to 2026
$2.7M
Targeting Clonal Hematopoiesis of Indeterminate Potential Using Human GeneticsDP5OD029586 · OD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BICK, ALEXANDER · 2020 to 2024
$2.3M
Training Program on Genetic Variation and Human PhenotypesT32GM145734 · NIGMS · VANDERBILT UNIVERSITY · PI Jennifer Below, DAVID C SAMUELS · 2022 to 2026
$1.6M
NHLBI NIH HHS R01 HL155426NIA NIH HHS R01 AG083736NIA NIH HHS R01 AG088657NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM080178NIGMS NIH HHS T32 GM145734NIH HHS DP5 OD029586
6 · The paper itself

Abstract

The application of transfer learning models to large scale single-cell datasets has enabled the development of single-cell foundation models (scFMs) that can predict cellular responses to perturbations in silico. Although these predictions can be experimentally tested, current scFMs are unable to "close the loop" and learn from these experiments to create better predictions. Here, we introduce a "closed-loop" framework that extends the scFM by incorporating perturbation data during model fine-tuning. Our closed-loop model improves prediction accuracy, increasing positive predictive value in the setting of T-cell activation three-fold. We applied this model to RUNX1-familial platelet disorder, a rare pediatric blood disorder and identified two therapeutic targets (mTOR and CD74-MIF signaling axis) and two novel pathways (protein kinase C and phosphoinositide 3-kinase). This work establishes that iterative incorporation of experimental data to foundation models enhances biological predictions, representing a crucial step toward realizing the promise of "virtual cell" models for biomedical discovery.

Identifiers

PMID40672312
PMCPMC12265564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.